<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0310">
 <label>62</label>
 <element-citation publication-type="journal" id="sbref0310">
  <person-group person-group-type="author">
   <name>
    <surname>Enevoldsen</surname>
    <given-names>F.C.</given-names>
   </name>
   <name>
    <surname>Sahana</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wehland</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Grimm</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Infanger</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>KrÃ¼ger</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Endothelin receptor antagonists: status quo and future perspectives for targeted therapy</article-title>
  <source>J Clin Med</source>
  <volume>9</volume>
  <year>2020</year>
  <fpage>824</fpage>
 </element-citation>
</ref>
